Tony Reiman Selected Research

Paclitaxel (Taxol)

3/2008	Protein abundance of class III beta-tubulin but not Delta2-alpha-tubulin or tau is related to paclitaxel response in carcinomas of unknown primary site.
6/2007	Class III beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tony Reiman Research Topics

Disease

29	Neoplasms (Cancer) 10/2023 - 07/2002
27	Multiple Myeloma 01/2023 - 02/2002
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 02/2007
6	Lymphoma (Lymphomas) 01/2019 - 09/2006
5	Waldenstrom Macroglobulinemia (Macroglobulinemia) 12/2008 - 03/2005
4	Disease Progression 04/2012 - 06/2005
3	Lung Neoplasms (Lung Cancer) 04/2012 - 03/2009
3	Breast Neoplasms (Breast Cancer) 01/2011 - 02/2007
3	Anemia 07/2010 - 09/2008
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 10/2021
2	Carcinogenesis 12/2020 - 11/2019
2	T-Cell Lymphoma (Lymphoma, T Cell) 03/2015 - 10/2010
2	Mycosis Fungoides 03/2015 - 10/2010
2	Hodgkin Disease (Hodgkin's Disease) 10/2012 - 07/2002
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2012 - 10/2010
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2011 - 06/2006
2	Sarcopenia 09/2010 - 04/2009
2	Fatigue 09/2009 - 09/2008
2	Monoclonal Gammopathy of Undetermined Significance 03/2009 - 04/2006
2	Carcinoma (Carcinomatosis) 03/2008 - 06/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2017
1	Compression Fractures (Compression Fracture) 06/2013
1	Pain (Aches) 06/2013
1	Spinal Cord Compression 06/2013
1	Spontaneous Fractures (Pathological Fracture) 06/2013
1	Dyspnea (Shortness of Breath) 02/2013
1	Hypesthesia (Numbness) 02/2013
1	Constipation 02/2013
1	Venous Thromboembolism 02/2013
1	Second Primary Neoplasms (Neoplasms, Second) 02/2013
1	Malignant Mesothelioma 11/2011
1	Exanthema (Rash) 10/2010
1	Overweight 08/2010
1	Hypertension (High Blood Pressure) 05/2009

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 03/2008 - 07/2002
5	Immunoglobulin M (IgM)IBA 09/2008 - 02/2002
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2019
4	Lenalidomide (CC 5013)FDA Link 01/2021 - 10/2010
4	Aurora KinasesIBA 01/2016 - 05/2007
4	TubulinIBA 02/2010 - 02/2007
3	carfilzomibIBA 01/2023 - 10/2012
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2009
3	beta-Aminoethyl Isothiourea (AET)IBA 01/2013 - 09/2009
3	Hyaluronan SynthasesIBA 12/2008 - 03/2005
2	Bortezomib (Velcade)FDA Link 01/2021 - 10/2012
2	Gemcitabine FDA Link 01/2019 - 07/2002
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 02/2007
2	Prednisone (Sone)FDA LinkGeneric 02/2013 - 02/2013
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 10/2012 - 09/2008
2	Fatty Acids (Saturated Fatty Acids)IBA 04/2012 - 09/2010
2	Phospholipids (Phosphatides)FDA LinkGeneric 04/2012 - 09/2010
2	Fish OilsIBA 08/2011 - 04/2011
2	AnthracyclinesIBA 02/2011 - 04/2009
2	Hemoglobins (Hemoglobin)IBA 07/2010 - 09/2008
2	HematinicsIBA 07/2010 - 05/2009
2	taxaneIBA 02/2010 - 04/2009
2	Fluorouracil (Carac)FDA LinkGeneric 04/2009 - 06/2007
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2008 - 06/2007
2	Aurora Kinase AIBA 03/2008 - 02/2008
2	Hyaluronic Acid (Hyaluronan)IBA 02/2005 - 08/2004
1	MicroRNAs (MicroRNA)IBA 10/2023
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2023
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2023
1	isatuximabIBA 01/2023
1	GoldIBA 10/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	interferon regulatory factor-4IBA 12/2020
1	Transcription Factors (Transcription Factor)IBA 12/2020
1	Guanosine Diphosphate (GDP)IBA 01/2019
1	romidepsin (FK228)FDA Link 01/2019
1	1- cyclopropyl- 3- (3- (5- morpholin- 4- ylmethyl- 1H- benzoimidazol- 2- yl)- 1H- pyrazol- 4- yl)ureaIBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	Thalidomide (Thalomid)FDA Link 02/2013
1	Melphalan (Alkeran)FDA LinkGeneric 02/2013
1	Proteasome InhibitorsIBA 10/2012
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 04/2012
1	Polo-Like Kinase 1IBA 12/2011
1	Sunitinib (Sutent)FDA Link 11/2011
1	Etoposide (VP 16)FDA LinkGeneric 02/2011
1	vosaroxinIBA 02/2011
1	Topoisomerase II InhibitorsIBA 02/2011
1	Epirubicin (Ellence)FDA LinkGeneric 01/2011
1	Eicosapentaenoic AcidIBA 09/2010
1	Docosahexaenoic AcidsIBA 09/2010
1	Epothilones (Epothilone)IBA 02/2010
1	thiamine triphosphorate (TTP)IBA 04/2009
1	Capecitabine (Xeloda)FDA Link 04/2009

Therapy/Procedure

18	Therapeutics 01/2021 - 05/2007
17	Drug Therapy (Chemotherapy) 10/2017 - 10/2003
3	Radiotherapy 06/2013 - 06/2006
2	Stem Cell Transplantation 10/2017 - 02/2013
2	Combination Drug Therapy (Combination Chemotherapy) 03/2015 - 10/2010
2	Blood Transfusion (Blood Transfusions) 07/2010 - 05/2009
1	Immunotherapy 01/2020
1	Adjuvant Chemotherapy 01/2020
1	Drug Tapering 03/2015
1	Kyphoplasty 06/2013
1	Behavior Control 10/2012